Literature DB >> 8550855

Gastric emptying and release of incretin hormones after glucose ingestion in humans.

J Schirra1, M Katschinski, C Weidmann, T Schäfer, U Wank, R Arnold, B Göke.   

Abstract

This study investigated in eight healthy male volunteers (a) the gastric emptying pattern of 50 and 100 grams of glucose; (b) its relation to the phase of interdigestive motility (phase I or II) existing when glucose was ingested; and (c) the interplay between gastric emptying or duodenal perfusion of glucose (1.1 and 2.2 kcal/min; identical total glucose loads as orally given) and release of glucose-dependent insulinotropic peptide (GIP), glucagon-like peptide-1(7-36)amide (GLP-1), C-peptide, insulin, and plasma glucose. The phase of interdigestive motility existing at the time of glucose ingestion did not affect gastric emptying or any metabolic parameter. Gastric emptying of glucose displayed a power exponential pattern with a short initial lag period. Duodenal delivery of glucose was not constant but exponentially declined over time. Increasing the glucose load reduced the rate of gastric emptying by 27.5% (P < 0.05) but increased the fractional duodenal delivery of glucose. Both glucose loads induced a fed motor pattern which was terminated by an antral phase III when approximately 95% of the meal had emptied. Plasma GLP-1 rose from basal levels of approximately 1 pmol/liter of peaks of 3.2 +/- 0.6 pmol/liter with 50 grams of glucose and of 7.2 +/- 1.6 pmol/liter with 100 grams of glucose. These peaks occurred 20 min after glucose intake irrespective of the load. A duodenal delivery of glucose exceeding 1.4 kcal/min was required to maintain GLP-1 release in contrast to ongoing GIP release with negligibly low emptying of glucose. Oral administration of glucose yielded higher GLP-1 and insulin releases but an equal GIP release compared with the isocaloric duodenal perfusion. We conclude that (a) gastric emptying of glucose displays a power exponential pattern with duodenal delivery exponentially declining over time and (b) a threshold rate of gastric emptying of glucose must be exceeded to release GLP-1, whereas GIP release is not controlled by gastric emptying.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8550855      PMCID: PMC507066          DOI: 10.1172/JCI118411

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  48 in total

1.  Relationship between oral glucose tolerance and gastric emptying in normal healthy subjects.

Authors:  M Horowitz; M A Edelbroek; J M Wishart; J W Straathof
Journal:  Diabetologia       Date:  1993-09       Impact factor: 10.122

2.  Analysis of gastric emptying data.

Authors:  J D Elashoff; T J Reedy; J H Meyer
Journal:  Gastroenterology       Date:  1982-12       Impact factor: 22.682

3.  Effect of a cholecystokinin antagonist on meal-stimulated insulin and pancreatic polypeptide release in humans.

Authors:  P Hildebrand; J W Ensinck; S Ketterer; F Delco; S Mossi; U Bangerter; C Beglinger
Journal:  J Clin Endocrinol Metab       Date:  1991-05       Impact factor: 5.958

4.  Integration of canine proximal gastric, antral, pyloric, and proximal duodenal motility during fasting and after a liquid meal.

Authors:  R Heddle; B W Miedema; K A Kelly
Journal:  Dig Dis Sci       Date:  1993-05       Impact factor: 3.199

5.  Effect of ethanol on absorption of a nutrient solution in the upper human intestine.

Authors:  A Pfeiffer; T Schmidt; N Vidon; H Kaess
Journal:  Scand J Gastroenterol       Date:  1993-06       Impact factor: 2.423

6.  Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man.

Authors:  A Wettergren; B Schjoldager; P E Mortensen; J Myhre; J Christiansen; J J Holst
Journal:  Dig Dis Sci       Date:  1993-04       Impact factor: 3.199

7.  Human antroduodenal motility, pyloric closure, and domperidone.

Authors:  I A Eyre-Brook; R Smallwood; A G Johnson
Journal:  Scand J Gastroenterol Suppl       Date:  1984

8.  Regulation of intestinal proglucagon-derived peptide secretion by glucose-dependent insulinotropic peptide in a novel enteroendocrine loop.

Authors:  J N Roberge; P L Brubaker
Journal:  Endocrinology       Date:  1993-07       Impact factor: 4.736

9.  Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man.

Authors:  R Eissele; R Göke; S Willemer; H P Harthus; H Vermeer; R Arnold; B Göke
Journal:  Eur J Clin Invest       Date:  1992-04       Impact factor: 4.686

10.  Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.

Authors:  M A Nauck; M M Heimesaat; C Orskov; J J Holst; R Ebert; W Creutzfeldt
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

View more
  91 in total

Review 1.  Glucagon-like peptide 1 (GLP-1).

Authors:  T D Müller; B Finan; S R Bloom; D D'Alessio; D J Drucker; P R Flatt; A Fritsche; F Gribble; H J Grill; J F Habener; J J Holst; W Langhans; J J Meier; M A Nauck; D Perez-Tilve; A Pocai; F Reimann; D A Sandoval; T W Schwartz; R J Seeley; K Stemmer; M Tang-Christensen; S C Woods; R D DiMarchi; M H Tschöp
Journal:  Mol Metab       Date:  2019-09-30       Impact factor: 7.422

2.  The effect of duodenal-jejunal bypass on glucose-dependent insulinotropic polypeptide secretion in Wistar rats.

Authors:  Tammy L Kindel; Stephanie M Yoder; David A D'Alessio; Patrick Tso
Journal:  Obes Surg       Date:  2010-02-23       Impact factor: 4.129

3.  Gastric emptying of orally administered glucose solutions and incretin hormone responses are unaffected by laparoscopic adjustable gastric banding.

Authors:  Lotte Usinger; Katrine B Hansen; Viggo B Kristiansen; Steen Larsen; Jens J Holst; Filip K Knop
Journal:  Obes Surg       Date:  2011-05       Impact factor: 4.129

Review 4.  Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down?

Authors:  M A Nauck; I Vardarli; C F Deacon; J J Holst; J J Meier
Journal:  Diabetologia       Date:  2010-09-25       Impact factor: 10.122

Review 5.  Targeting beta-cell mass in type 2 diabetes: promise and limitations of new drugs based on incretins.

Authors:  Marzieh Salehi; Benedikt A Aulinger; David A D'Alessio
Journal:  Endocr Rev       Date:  2008-02-21       Impact factor: 19.871

6.  A Simple, Realistic Stochastic Model of Gastric Emptying.

Authors:  Jiraphat Yokrattanasak; Andrea De Gaetano; Simona Panunzi; Pairote Satiracoo; Wayne M Lawton; Yongwimon Lenbury
Journal:  PLoS One       Date:  2016-04-08       Impact factor: 3.240

7.  Ghrelin Impairs Prandial Glucose Tolerance and Insulin Secretion in Healthy Humans Despite Increasing GLP-1.

Authors:  Jenny Tong; Harold W Davis; Amalia Gastaldelli; David D'Alessio
Journal:  J Clin Endocrinol Metab       Date:  2016-04-07       Impact factor: 5.958

8.  Effects of dietary fibers on weight gain, carbohydrate metabolism, and gastric ghrelin gene expression in mice fed a high-fat diet.

Authors:  Zhong Q Wang; Aamir R Zuberi; Xian H Zhang; Jacalyn Macgowan; Jianhua Qin; Xin Ye; Leslie Son; Qinglin Wu; Kun Lian; William T Cefalu
Journal:  Metabolism       Date:  2007-12       Impact factor: 8.694

Review 9.  The role of incretins in glucose homeostasis and diabetes treatment.

Authors:  Wook Kim; Josephine M Egan
Journal:  Pharmacol Rev       Date:  2008-12-12       Impact factor: 25.468

10.  Regulation of islet hormone release and gastric emptying by endogenous glucagon-like peptide 1 after glucose ingestion.

Authors:  Marzieh Salehi; Torsten P Vahl; David A D'Alessio
Journal:  J Clin Endocrinol Metab       Date:  2008-09-30       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.